2HWO | A:255-340; B:258-340 | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR |
2HWP | A:256-340; B:258-340 | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR PD168393 |
2J0L | A:411-501 | CRYSTAL STRUCTURE OF A THE ACTIVE CONFORMATION OF THE KINASE DOMAIN OF FOCAL ADHESION KINASE WITH A PHOSPHORYLATED ACTIVATION LOOP. |
2J0M | B:414-501 | CRYSTAL STRUCTURE A TWO-CHAIN COMPLEX BETWEEN THE FERM AND KINASE DOMAINS OF FOCAL ADHESION KINASE. |
2JKK | A:413-501 | FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR |
2JKM | A:413-501 | FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR |
2JKO | A:415-501 | FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR |
2JKQ | A:414-501 | FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR |
2OIQ | A:256-340; B:258-340 | CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH THE CANCER DRUG IMATINIB. |
2PTK | A:259-344 | CHICKEN SRC TYROSINE KINASE |
2QI8 | A:257-340; B:258-340 | CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN |
2QLQ | A:256-340; B:257-340 | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN WITH COVALENT INHIBITOR RL3 |
2QQ7 | A:257-340; B:258-340 | CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN WITH IRREVERSIBLE INHIBITOR |
3DQW | A:255-340; B:255-340; D:257-340; C:258-340 | C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS |
3DQX | A:259-340; B:259-340 | CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH ATPGS |
3EL7 | A:257-340 | CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 3 |
3EL8 | A:258-340; B:256-340 | CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 5 |
3F3T | A:257-340; B:256-340 | KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL38 (TYPE III) |
3F3U | A:257-340; B:257-340 | KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL37 (TYPE III) |
3F3V | B:256-340; A:257-340 | KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL45 (TYPE II) |
3F3W | A:257-340; B:258-340 | DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH INHIBITOR RL45 (TYPE II) |
3G5D | B:258-340; A:257-340 | KINASE DOMAIN OF CSRC IN COMPLEX WITH DASATINIB |
3G6G | A:256-340; B:256-340 | EQUALLY POTENT INHIBITION OF C-SRC AND ABL BY COMPOUNDS THAT RECOGNIZE INACTIVE KINASE CONFORMATIONS |
3G6H | A:258-340; B:258-340 | SRC THR338ILE INHIBITED IN THE DFG-ASP-OUT CONFORMATION |